and then the brand version of that medication, called gl lumetzglumetza cost $6,500. if you look at the medication by population that only cost $7 per prescription. so we really want to drivualization towardif lent medication but at a lower cost. >> we've had these discussions in the past over drugs and many times the members would say that i guess there are different binders and many have different drugs. they claim they are the same but they are not, i guess. >> we are just following the fda guidelines on approved medications. on further illustration of this slide on slide 1, the agents where doxopene hydro chloride would be moving from tier 1 to tier 3 where the cros cross crotozome. these are examples and commissioner scott i heard your request. and we will get back to you. >> thank you. >> moving on to slide 8. so based on the utilization of hss in calendar year 2017 for the impacted prescriptions on the very left there, would be 117hmo members would be impacted. during calendar year 2017, 27,000hss members had prescriptions filled. so of those 27,000 members, 11

and then the brand version of that medication, called gl lumetzglumetza cost $6,500. if you look at the medication by population that only cost $7 per prescription. so we really want to drivualization towardif lent medication but at a lower cost. >> we've had these discussions in the past over drugs and many times the members would say that i guess there are different binders and many have different drugs. they claim they are the same but they are not, i guess. >> we are just following the fda